TY - JOUR AU - Hegewisch-Becker, S. AU - Graeven, U. AU - Lerchenmüller, C. A. AU - Killing, B. AU - Depenbusch, R. AU - Steffens, C. -. C. PY - 2015 DA - 2015// TI - Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00042-X DO - 10.1016/S1470-2045(15)00042-X ID - Hegewisch-Becker2015 ER - TY - JOUR AU - Sunakawa, Y. AU - Bekaii-Saab, T. AU - Stintzing, S. PY - 2016 DA - 2016// TI - Reconsidering the benefit of intermittent versus continuous treatment in the maintenance treatment setting of metastatic colorectal cancer JO - Cancer Treat Rev VL - 45 UR - https://doi.org/10.1016/j.ctrv.2016.03.007 DO - 10.1016/j.ctrv.2016.03.007 ID - Sunakawa2016 ER - TY - JOUR AU - Pavlidis, E. T. AU - Pavlidis, T. E. PY - 2013 DA - 2013// TI - Role of bevacizumab in colorectal cancer growth and its adverse effects: a review JO - World J Gastroenterol WJG VL - 19 UR - https://doi.org/10.3748/wjg.v19.i31.5051 DO - 10.3748/wjg.v19.i31.5051 ID - Pavlidis2013 ER - TY - JOUR AU - Tamburini, E. AU - Rudnas, B. AU - Santelmo, C. AU - Drudi, F. AU - Gianni, L. AU - Nicoletti, S. V. L. PY - 2016 DA - 2016// TI - Maintenance based Bevacizumab versus complete stop or continuous therapy after induction therapy in first line treatment of stage IV colorectal cancer: a meta-analysis of randomized clinical trials JO - Crit Rev Oncol Hematol VL - 104 UR - https://doi.org/10.1016/j.critrevonc.2016.05.016 DO - 10.1016/j.critrevonc.2016.05.016 ID - Tamburini2016 ER - TY - JOUR AU - Xu, W. AU - Gong, Y. AU - Kuang, M. AU - Wu, P. AU - Cao, C. AU - Chen, J. PY - 2017 DA - 2017// TI - Survival benefit and safety of Bevacizumab in combination with Erlotinib as maintenance therapy in patients with metastatic colorectal Cancer: a meta-analysis JO - Clin Drug Investig VL - 37 UR - https://doi.org/10.1007/s40261-016-0465-0 DO - 10.1007/s40261-016-0465-0 ID - Xu2017 ER - TY - JOUR AU - Aparicio, T. AU - Linot, B. AU - Malicot, K. AU - Bouché, O. AU - Boige, V. AU - François, E. PY - 2015 DA - 2015// TI - FOLFIRI+bevacizumab induction chemotherapy followed by bevacizumab or observation in metastatic colorectal cancer, a phase III trial (PRODIGE 9--FFCD 0802) JO - Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver VL - 47 ID - Aparicio2015 ER - TY - JOUR AU - Mansournia, M. A. AU - Higgins, J. P. T. AU - Sterne, J. A. C. AU - Hernán, M. A. PY - 2017 DA - 2017// TI - Biases in randomized trials: a conversation between trialists and epidemiologists JO - Epidemiol Camb Mass VL - 28 UR - https://doi.org/10.1097/EDE.0000000000000564 DO - 10.1097/EDE.0000000000000564 ID - Mansournia2017 ER - TY - JOUR AU - Carlomagno, C. AU - Stefano, A. AU - Rosanova, M. AU - Falco, S. AU - Attademo, L. AU - Fiore, G. PY - 2019 DA - 2019// TI - Multiple treatment lines and prognosis in metastatic colorectal cancer patients JO - Cancer Metastasis Rev. VL - 38 UR - https://doi.org/10.1007/s10555-018-9748-7 DO - 10.1007/s10555-018-9748-7 ID - Carlomagno2019 ER - TY - JOUR AU - Greenland, S. AU - Robins, J. M. AU - Pearl, J. PY - 1999 DA - 1999// TI - Confounding and collapsibility in causal inference JO - Stat Sci VL - 14 UR - https://doi.org/10.1214/ss/1009211805 DO - 10.1214/ss/1009211805 ID - Greenland1999 ER - TY - JOUR AU - Montedori, A. AU - Bonacini, M. I. AU - Casazza, G. AU - Luchetta, M. L. AU - Duca, P. AU - Cozzolino, F. PY - 2011 DA - 2011// TI - Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study JO - Trials VL - 12 UR - https://doi.org/10.1186/1745-6215-12-58 DO - 10.1186/1745-6215-12-58 ID - Montedori2011 ER - TY - JOUR AU - Pocock, S. J. AU - McMurray, J. J. V. AU - Collier, T. J. PY - 2015 DA - 2015// TI - Statistical controversies in reporting of clinical trials: part 2 of a 4-part series on statistics for clinical trials JO - J Am Coll Cardiol VL - 66 UR - https://doi.org/10.1016/j.jacc.2015.10.023 DO - 10.1016/j.jacc.2015.10.023 ID - Pocock2015 ER - TY - JOUR AU - Cox, D. R. PY - 1972 DA - 1972// TI - Regression models and life-tables JO - J R Stat Soc Ser B Methodol VL - 34 ID - Cox1972 ER - TY - JOUR AU - Wozniak, K. M. AU - Vornov, J. J. AU - Wu, Y. AU - Nomoto, K. AU - Littlefield, B. A. AU - DesJardins, C. PY - 2016 DA - 2016// TI - Sustained accumulation of microtubule-binding chemotherapy drugs in the peripheral nervous system: correlations with time course and neurotoxic severity JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-2525 DO - 10.1158/0008-5472.CAN-15-2525 ID - Wozniak2016 ER - TY - JOUR AU - Mohelnikova-Duchonova, B. AU - Melichar, B. AU - Soucek, P. PY - 2014 DA - 2014// TI - FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy JO - World J Gastroenterol WJG. VL - 20 UR - https://doi.org/10.3748/wjg.v20.i30.10316 DO - 10.3748/wjg.v20.i30.10316 ID - Mohelnikova-Duchonova2014 ER - TY - JOUR AU - Farran, B. AU - McGurnaghan, S. AU - Looker, H. C. AU - Livingstone, S. AU - Lahnsteiner, E. AU - Colhoun, H. M. PY - 2017 DA - 2017// TI - Modelling cumulative exposure for inference about drug effects in observational studies JO - Pharmacoepidemiol Drug Saf VL - 26 UR - https://doi.org/10.1002/pds.4327 DO - 10.1002/pds.4327 ID - Farran2017 ER - TY - JOUR AU - Abrahamowicz, M. AU - Beauchamp, M. -. E. AU - Sylvestre, M. -. P. PY - 2012 DA - 2012// TI - Comparison of alternative models for linking drug exposure with adverse effects JO - Stat Med VL - 31 UR - https://doi.org/10.1002/sim.4343 DO - 10.1002/sim.4343 ID - Abrahamowicz2012 ER - TY - JOUR AU - Vocht, F. AU - Burstyn, I. AU - Sanguanchaiyakrit, N. PY - 2015 DA - 2015// TI - Rethinking cumulative exposure in epidemiology, again JO - J Expo Sci Environ Epidemiol VL - 25 UR - https://doi.org/10.1038/jes.2014.58 DO - 10.1038/jes.2014.58 ID - Vocht2015 ER - TY - JOUR AU - Wang, M. AU - Liao, X. AU - Laden, F. AU - Spiegelman, D. PY - 2016 DA - 2016// TI - Quantifying risk over the life course - latency, age-related susceptibility, and other time-varying exposure metrics JO - Stat Med VL - 35 UR - https://doi.org/10.1002/sim.6864 DO - 10.1002/sim.6864 ID - Wang2016 ER - TY - JOUR AU - Robinson, D. E. AU - Staa, T. P. AU - Dennison, E. M. AU - Cooper, C. AU - Dixon, W. G. PY - 2018 DA - 2018// TI - The limitations of using simple definitions of glucocorticoid exposure to predict fracture risk: a cohort study JO - Bone VL - 117 UR - https://doi.org/10.1016/j.bone.2018.09.004 DO - 10.1016/j.bone.2018.09.004 ID - Robinson2018 ER - TY - JOUR AU - Alsabbagh, M. W. AU - Eurich, D. AU - Lix, L. M. AU - Wilson, T. W. AU - Blackburn, D. F. PY - 2017 DA - 2017// TI - Does the association between adherence to statin medications and mortality depend on measurement approach? A retrospective cohort study JO - BMC Med Res Methodol VL - 17 UR - https://doi.org/10.1186/s12874-017-0339-z DO - 10.1186/s12874-017-0339-z ID - Alsabbagh2017 ER - TY - JOUR AU - Abrahamowicz, M. AU - Bartlett, G. AU - Tamblyn, R. AU - Berger, R. PY - 2006 DA - 2006// TI - Modeling cumulative dose and exposure duration provided insights regarding the associations between benzodiazepines and injuries JO - J Clin Epidemiol VL - 59 UR - https://doi.org/10.1016/j.jclinepi.2005.01.021 DO - 10.1016/j.jclinepi.2005.01.021 ID - Abrahamowicz2006 ER - TY - JOUR AU - Sylvestre, M. -. P. AU - Abrahamowicz, M. PY - 2009 DA - 2009// TI - Flexible modeling of the cumulative effects of time-dependent exposures on the hazard JO - Stat Med VL - 28 UR - https://doi.org/10.1002/sim.3701 DO - 10.1002/sim.3701 ID - Sylvestre2009 ER - TY - JOUR AU - Gasparrini, A. PY - 2014 DA - 2014// TI - Modeling exposure-lag-response associations with distributed lag non-linear models JO - Stat Med VL - 33 UR - https://doi.org/10.1002/sim.5963 DO - 10.1002/sim.5963 ID - Gasparrini2014 ER - TY - JOUR AU - Aparicio, T. AU - Ghiringhelli, F. AU - Boige, V. AU - Malicot, K. AU - Taieb, J. AU - Bouché, O. PY - 2018 DA - 2018// TI - Bevacizumab maintenance versus no maintenance during chemotherapy-free intervals in metastatic colorectal Cancer: a randomized phase III trial (PRODIGE 9) JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2017.75.2931 DO - 10.1200/JCO.2017.75.2931 ID - Aparicio2018 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. AU - Schwartz, L. H. AU - Sargent, D. AU - Ford, R. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer Oxf Engl 1990 VL - 45 ID - Eisenhauer2009 ER - TY - JOUR AU - Wainwright, N. W. J. AU - Surtees, P. G. PY - 2002 DA - 2002// TI - Time-varying exposure and the impact of stressful life events on onset of affective disorder JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1159 DO - 10.1002/sim.1159 ID - Wainwright2002 ER - TY - JOUR AU - Panoilia, E. AU - Schindler, E. AU - Samantas, E. AU - Aravantinos, G. AU - Kalofonos, H. P. AU - Christodoulou, C. PY - 2015 DA - 2015// TI - A pharmacokinetic binding model for bevacizumab and VEGF165 in colorectal cancer patients JO - Cancer Chemother Pharmacol VL - 75 UR - https://doi.org/10.1007/s00280-015-2701-3 DO - 10.1007/s00280-015-2701-3 ID - Panoilia2015 ER - TY - JOUR AU - Xiao, Y. AU - Abrahamowicz, M. AU - Moodie, E. E. M. AU - Weber, R. AU - Young, J. PY - 2014 DA - 2014// TI - Flexible marginal structural models for estimating the cumulative effect of a time-dependent treatment on the Hazard: reassessing the cardiovascular risks of Didanosine treatment in the Swiss HIV cohort study JO - J Am Stat Assoc VL - 109 UR - https://doi.org/10.1080/01621459.2013.872650 DO - 10.1080/01621459.2013.872650 ID - Xiao2014 ER - TY - JOUR AU - Danieli, C. AU - Abrahamowicz, M. PY - 2019 DA - 2019// TI - Competing risks modeling of cumulative effects of time-varying drug exposures JO - Stat Methods Med Res VL - 28 UR - https://doi.org/10.1177/0962280217720947 DO - 10.1177/0962280217720947 ID - Danieli2019 ER - TY - STD TI - Sylvestre M-P, Beauchamp M-E, Kyle RP, Abrahamowicz M. WCE: Weighted Cumulative Exposure Models. R Package [Internet]. Available from: https://CRAN.R-project.org/package=WCE. UR - https://cran.r-project.org/package=WCE ID - ref30 ER - TY - JOUR AU - Quantin, C. AU - Abrahamowicz, M. AU - Moreau, T. AU - Bartlett, G. AU - MacKenzie, T. AU - Tazi, M. A. PY - 1999 DA - 1999// TI - Variation over time of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models JO - Am J Epidemiol VL - 150 UR - https://doi.org/10.1093/oxfordjournals.aje.a009945 DO - 10.1093/oxfordjournals.aje.a009945 ID - Quantin1999 ER - TY - JOUR AU - Hernan, M. A. AU - Brumback, B. AU - Robins, J. M. PY - 2001 DA - 2001// TI - Marginal structural models to estimate the joint causal effect of nonrandomized treatments JO - J Am Stat Assoc VL - 96 UR - https://doi.org/10.1198/016214501753168154 DO - 10.1198/016214501753168154 ID - Hernan2001 ER - TY - JOUR AU - Rui, Y. AU - Wang, C. AU - Zhou, Z. AU - Zhong, X. AU - Yu, Y. PY - 2015 DA - 2015// TI - K-Ras mutation and prognosis of colorectal cancer: a meta-analysis JO - Hepatogastroenterology. VL - 62 ID - Rui2015 ER - TY - JOUR AU - Jang, H. J. AU - Kim, B. J. AU - Kim, J. H. AU - Kim, H. S. PY - 2017 DA - 2017// TI - The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.20314 DO - 10.18632/oncotarget.20314 ID - Jang2017 ER -